Clinical relevance of silent atrial fibrillation: Prevalence, prognosis, quality of life, and management

Journal of Interventional Cardiac Electrophysiology

Volumn 4, Issue 2, 2000, Pages 369-382

  Savelieva, Irina ^a   Camm, A John ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Asymptomatic; Atrial arrhythmias; Atrial fibrillation

Indexed keywords

CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DYSPNEA; FATIGUE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART PALPITATION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYNCOPE; VERTIGO;

ATRIAL FIBRILLATION; HUMANS; PREVALENCE; PROGNOSIS; QUALITY OF LIFE;

EID: 0033817509     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009823001707     Document Type: Review

References (77)

1. Auricular fibrillation: A common clinical condition
2. Five year follow-up of 101 elderly subjects by means of long-term ambulatory cardiac monitoring
3. Incidence of and risk factors for atrial fibrillation in older adults
4. Prevalence of electrocardiogram in old people
5. Electrocardiographic findings in the aged
6. Epidemiologic features of chronic atrial fibrillation: The Framingham Study
7. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba follow-up study
8. Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry)
9. Atrial fibrillation: A major contributor to stroke in the elderly
10. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
11. Atrial fibrillation. A tachycardia-induced atrial cardiomyopathy
12. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: The AIDA study
13. Incidence of atrial arrhythmias in patients with dual-chamber pacemakers: Value of the pacemaker Holter function
14. Number, duration and frequency of non-treated atrial fibrillation episodes observed during the Metrix Automatic Implantable Atrial Defibrillator Trial
15. Follow-up of atrial fibrillation: The initial experience of the Canadian Registry of Atrial Fibrillation
16. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study
17. The natural history of lone atrial fibrillation: A population-based study over three decades
18. Mid-term clinical and prognostic evaluation of idiopathic atrial fibrillation
19. The rhythm of the heart in active elderly subjects
20. Changes in the electrocardiogram in the elderly patient: The limits between normality and pathology
21. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)
22. Sympatho-vagal influence in atrial fibrillation
23. Cardiac arrhythmias in active elderly persons - Age dependence on heart rate and arrhythmias
24. Holter monitoring in patients with mitral stenosis and sinus rhythm
25. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia
26. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation a transtelephonic monitoring study
27. The incidence of asymptomatic paroxysmal atrial fibrillation in patients treated with propranolol or propafenone
28. Twenty-four-hour ambulatory electrocardiography in elderly subjects: Prevalence of various arrhythmias and prognostic implications (report from the Bronx Longitudinal Aging Study)
29. Characterization of different subsets of atrial fibrillation in general practice in France: The ALFA Study
30. Independent risk factors for atrial fibrillation in a population based cohort: The Framingham Heart Study
31. Duration of atrial fibrillation and imminence of stroke: The Framingham Study
32. Newly diagnosed atrial fibrillation and acute stroke: The Framingham Study
33. Cerebrovascular disease in dementia: The importance of atrial fibrillation
34. Asymptomatic cerebral infarction in patients with chronic atrial fibrillation
35. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation
36. Prevalence of silent stroke in patients presenting with initial stroke: The Framingham Study
37. Asymptomatic cerebral infarction in patients with atrial fibrillation
38. Echocardiography and cerebral computed tomography in chronic atrial fibrillation
39. Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants: A prospective Study
40. Neurophysiological deficits in asymptomatic atrial fibrillation
41. Atrial fibrillation and dementia in a population-based study: The Rotterdam Study
42. Effect of chronic atrial fibrillation on regional cerebral blood flow
43. Auricular fibrillation with congestive failure and no other evidence of organic heart disease
44. Auricular fibrillation without other evidence of heart disease: A cause of reversible heart failure
45. Prognostic significance of atrial fibrillation in advanced heart failure: A study of 390 patients
46. Left ventricular dysfunction due to atrial fibrillation inpatients initially believed to have idiopathic dilated cardiomyopathy
47. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: Complete recovery after restoration of sinus rhythm
48. Reversion of tachycardiomyopathy after β-blocker
49. Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy
50. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease
51. Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction
52. Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction
53. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation
54. A prospective hemodynamic evaluation of patients with chronic atrial fibrillation undergoing radiofrequency catheter ablation of the atrioventricular junction
55. Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: Impact of treatment in paroxysmal and established atrial fibrillation
56. Atrioventricular nodal function in atrial fibrillation: What is the optimum ventricular rate?
57. Effect of an irregular ventricular rhythm on cardiac output
58. Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response
59. Hypertrophic cardiomyopathy in Tuscany: Clinical course and outcome in an unselected regional population
60. Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis
61. Atrial fibrillation in hypertrophic cardiomyopathy: A longitudinal study
62. Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance
63. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation
64. Atrioventricular nodal ablation and implantation of mode switching dual chamber pacemakers: Effective treatment for drug refractory paroxysmal atrial fibrillation
65. Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation
66. Progression of permanent atrial fibrillation after atrioventricular junction ablation and dual-chamber pacemaker implantation in patients with paroxysmal atrial tachyarrhythmias
67. Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery
68. Atrial arrhythmias after cardiothoracic surgery
69. Recurrent atrial arrhythmias following treatment for postoperative atrial fibrillation after coronary bypass operations
70. Prevalence and prognosis of electrocardiographic findings in middle-aged men
71. Atrial fibrillation in elderly, anbulatory patients
72. Mortality in an insured population with atrial fibrillation
73. Quality of life and exercise tolerance in elderly, ambulatory patients with chronic atrial fibrillation
74. Sinus rhythm at the time of assessment is associated with better quality of life than atrial fibrillation or flutter results from the Canadian Trial of Atrial Fibrillation
75. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation
76. Subclinical thyroid dysfunction
77. How useful is thyroid function testing in patients with recent-onset atrial fibrillation?